['lizbeth]

Galena Biopharma provides E75 (Neuvax) which is the first generation vaccine. This is being used in a clinical trial for lower expressors of Her2 that do not qualify for Herceptin. My clinical trial nurse, Karen Escamilla, is helping to obtain more enrollment. If you know of anyone who is a lower expressor of Her2 please direct them to the clinical trial information on the internet, put them in touch with Karen at Brooke Army Medical Center, or contact me and I'll pass along the contact information.

Antigen Express provides the second generation vaccine, AE37 - which Dr. Peoples is overseeing the the Walter Reed vaccine trial. This is the vaccine that SandraGA is receiving in her arm of "our" vaccine trial. Anna4969 and I are participating in this trial in the GP2 arm.

In our trial the difference is based on HLA-A2+ or HLA-A2-, a human leukocyte antigen. I'm positive, hence the GP2. Sandra is negative and in the AE37.

I'm very enthusiastic about these vaccine clinical trials, along with TDM1, pertuzumab - and anything else that mobilizes that immune system to conquer our cancer. I'm very unhappy about any treatment that uses chemotherapy that wipes out healthy cells along with cancer cells.

Again, if you know of any ladies who are lower expressors of Her2 (maybe in your support groups or going through treatment at the same time) please encourage them to consider a NeuVax clinical trial.